Therapeutic Potential for Intractable Asthma by Targeting L-Type Amino Acid Transporter 1.

Amino Acid Transport Systems / metabolism Asthma Cytokines / metabolism Humans Immunity, Innate Inflammation Lymphocytes / metabolism Th2 Cells
L-type amino acid transporter (LAT) 1 Th17 steroid-resistant asthma

Journal

Biomolecules
ISSN: 2218-273X
Titre abrégé: Biomolecules
Pays: Switzerland
ID NLM: 101596414

Informations de publication

Date de publication:
08 04 2022
Historique:
received: 18 03 2022
revised: 06 04 2022
accepted: 06 04 2022
entrez: 23 4 2022
pubmed: 24 4 2022
medline: 27 4 2022
Statut: epublish

Résumé

Bronchial asthma is a chronic disease characterized by airway inflammation, obstruction, and hyperresponsiveness. CD4

Identifiants

DOI: 10.3390/biom12040553 PMID: 35454142 PMC: PMC9029068
pubmed: 35454142
pii: biom12040553
doi: 10.3390/biom12040553
pmc: PMC9029068
pii:
doi:

Substances chimiques

Amino Acid Transport Systems 0
Cytokines 0

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Références

Pharmacol Ther. 2022 Feb;230:107964
pubmed: 34390745
Immunity. 2010 Aug 27;33(2):192-202
pubmed: 20674401
Nat Immunol. 2013 May;14(5):500-8
pubmed: 23525088
Allergol Int. 2020 Apr;69(2):167-177
pubmed: 32067933
Allergy. 2020 Feb;75(2):311-325
pubmed: 31309578
Biol Pharm Bull. 2020;43(1):31-35
pubmed: 31902928
Allergol Int. 2020 Jul;69(3):455-458
pubmed: 31928946
J Allergy Clin Immunol. 2013 Aug;132(2):297-304.e3
pubmed: 23683514
Allergy. 2020 Feb;75(2):463-467
pubmed: 31403710
Int J Cancer. 2016 Dec 1;139(11):2529-39
pubmed: 27486861
J Biol Chem. 1999 Jan 29;274(5):3009-16
pubmed: 9915839
Nat Immunol. 2010 Oct;11(10):928-35
pubmed: 20802484
Clin Exp Allergy. 2002 Jan;32(1):140-8
pubmed: 12002731
Allergy. 2020 Feb;75(2):302-310
pubmed: 31267562
Oncol Rep. 2012 Sep;28(3):862-6
pubmed: 22736142
Allergy. 2020 Dec;75(12):3087-3099
pubmed: 33040364
J Allergy Clin Immunol. 2005 Feb;115(2):309-15
pubmed: 15696086
Int Arch Allergy Immunol. 2010;152 Suppl 1:79-82
pubmed: 20523068
Am J Respir Crit Care Med. 2013 Dec 1;188(11):1294-302
pubmed: 24200404
J Immunol. 1991 Mar 15;146(6):1829-35
pubmed: 1672334
Biochem Biophys Res Commun. 2011 Mar 25;406(4):649-55
pubmed: 21371427
Nat Commun. 2013;4:2675
pubmed: 24157859
J Clin Invest. 2015 Aug 3;125(8):3037-50
pubmed: 26121748
Trends Biochem Sci. 2018 Oct;43(10):752-789
pubmed: 30177408
Life Sci. 2021 Feb 15;267:118973
pubmed: 33400932
Clin Exp Allergy. 2012 Feb;42(2):315-25
pubmed: 22092376
J Clin Invest. 1991 May;87(5):1541-6
pubmed: 2022726
J Allergy Clin Immunol. 2020 Jan;145(1):199-214.e11
pubmed: 31605740
Allergy. 2020 Dec;75(12):3100-3111
pubmed: 33068299
J Immunol. 2021 Apr 1;206(7):1409-1417
pubmed: 33753565
Biomed Pharmacother. 2013 Oct;67(8):693-9
pubmed: 23809372
Science. 2004 Sep 17;305(5691):1773-6
pubmed: 15375267
EMBO Rep. 2020 Jan 7;21(1):e48469
pubmed: 31789450
Invest New Drugs. 2020 Oct;38(5):1495-1506
pubmed: 32198649
Allergy. 2020 Jul;75(7):1555-1563
pubmed: 32124991
Am Rev Respir Dis. 1993 Mar;147(3):540-7
pubmed: 8095124
J Immunol. 2001 Aug 15;167(4):2349-53
pubmed: 11490024
J Allergy Clin Immunol. 2003 Jun;111(6):1319-27
pubmed: 12789235
Immunol Cell Biol. 2016 Jul;94(6):612-7
pubmed: 26926958
Allergy. 2021 Nov;76(11):3390-3407
pubmed: 34392546
Allergy. 2020 Mar;75(3):546-560
pubmed: 31444793
Cancer Sci. 2010 Jan;101(1):173-9
pubmed: 19900191
J Biol Chem. 1998 Sep 11;273(37):23629-32
pubmed: 9726963
Front Immunol. 2020 Nov 30;11:603312
pubmed: 33329598
Chest. 2017 May;151(5):1122-1130
pubmed: 27818326
Allergy. 2020 Jul;75(7):1582-1605
pubmed: 32319104
Respir Med. 2003 Jun;97(6):726-33
pubmed: 12814161
J Allergy Clin Immunol. 2001 Sep;108(3):430-8
pubmed: 11544464
J Urol. 2016 May;195(5):1588-1597
pubmed: 26682754
Mol Pharmacol. 2002 Apr;61(4):729-37
pubmed: 11901210
Allergy. 2020 Nov;75(11):2794-2804
pubmed: 32737888
J Immunol. 2008 Sep 15;181(6):4089-97
pubmed: 18768865
Proc Natl Acad Sci U S A. 2013 Apr 2;110(14):5480-5
pubmed: 23509259
Allergy. 2020 Mar;75(3):524-534
pubmed: 31187881
World J Gastrointest Oncol. 2017 Jan 15;9(1):21-29
pubmed: 28144396
Nat Med. 2012 Mar 04;18(4):547-54
pubmed: 22388091
J Allergy Clin Immunol. 2003 Jun;111(6):1293-8
pubmed: 12789232
Allergy. 2011 Aug;66(8):989-98
pubmed: 21375540
Allergol Int. 2020 Apr;69(2):197-203
pubmed: 31974038
Sci Signal. 2019 Jul 09;12(589):
pubmed: 31289211
J Exp Med. 2008 Jun 9;205(6):1285-92
pubmed: 18490489
J Immunol. 2013 Oct 15;191(8):4080-5
pubmed: 24038088
Allergy. 2020 Oct;75(10):2491-2502
pubmed: 32249957
Asia Pac Allergy. 2021 Jul 19;11(3):e33
pubmed: 34386409
Int J Mol Sci. 2020 Oct 11;21(20):
pubmed: 33050549
Pharmacol Res. 2020 Oct;160:105189
pubmed: 32911071
Allergol Int. 2017 Sep;66S:S35-S40
pubmed: 28755856
Nat Genet. 2021 Jan;53(1):16-26
pubmed: 33414552

Auteurs

Keitaro Hayashi (K)

Department of Pharmacology and Toxicology, Dokkyo Medical University School of Medicine, Tochigi 321-0293, Japan.
ORCID: 0000-0002-0306-1074

Osamu Kaminuma (O)

Department of Disease Model, Research Institute of Radiation Biology and Medicine, Hiroshima University, Hiroshima 734-8553, Japan.
ORCID: 0000-0003-1211-0410

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female

Evaluation of Low-Value Services Across Major Medicare Advantage Insurers and Traditional Medicare.

Ciara Duggan, Adam L Beckman, Ishani Ganguli et al.
1.00
Humans United States Aged Cross-Sectional Studies Medicare Part C

Effectiveness of Virtual Yoga for Chronic Low Back Pain: A Randomized Clinical Trial.

Hallie Tankha, Devyn Gaskins, Amanda Shallcross et al.
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH

questionsmedicales.fr › Acides aminés, peptides et protéines › Protéines › Protéines membranaires › Protéines de transport membranaire › Systèmes de transport d'acides aminés › Therapeutic Potential for Intractable Asthma...
questionsmedicales.fr › Maladies du système immunitaire › Hypersensibilité › Hypersensibilité immédiate › Hypersensibilité respiratoire › Asthme › Therapeutic Potential for Intractable Asthma...
questionsmedicales.fr › Facteurs biologiques › Protéines et peptides de signalisation intercellulaire › Cytokines › Therapeutic Potential for Intractable Asthma...
questionsmedicales.fr › Eucaryotes › Animaux › Chordés › Vertébrés › Mammifères › Eutheria › Primates › Haplorhini › Catarrhini › Hominidae › Humains › Therapeutic Potential for Intractable Asthma...
questionsmedicales.fr › Phénomènes du système immunitaire › Immunité › Immunité innée › Therapeutic Potential for Intractable Asthma...
questionsmedicales.fr › États, signes et symptômes pathologiques › Processus pathologiques › Inflammation › Therapeutic Potential for Intractable Asthma...
questionsmedicales.fr › Systèmes sanguin et immunitaire › Système immunitaire › Leucocytes › Agranulocytes › Lymphocytes › Therapeutic Potential for Intractable Asthma...
questionsmedicales.fr › Systèmes sanguin et immunitaire › Système immunitaire › Leucocytes › Agranulocytes › Lymphocytes › Lymphocytes T › Sous-populations de lymphocytes T › Lymphocytes T auxiliaires › Lymphocytes auxiliaires Th2 › Therapeutic Potential for Intractable Asthma...